Bed Bath & Beyond Past Earnings Performance
Past criteria checks 0/6
Bed Bath & Beyond's earnings have been declining at an average annual rate of -48%, while the Specialty Retail industry saw earnings declining at 2.8% annually. Revenues have been declining at an average rate of 21.7% per year.
Key information
-48.02%
Earnings growth rate
-47.26%
EPS growth rate
| Specialty Retail Industry Growth | 26.64% |
| Revenue growth rate | -21.74% |
| Return on equity | -30.18% |
| Net Margin | -5.76% |
| Last Earnings Update | 31 Mar 2026 |
Recent past performance updates
Recent updates
Bed Bath & Beyond: Still Unprofitable, Still Burning Through Cash
Apr 29
BBBY: Core Business Inflection And SKU Consolidation Will Drive Future Upside
Analysts have trimmed their average price targets for Bed Bath & Beyond to a range of about $7 to $8 from prior levels near $10 to $13, citing a mix of sequential improvement in the core business, cautious views on the execution of internal initiatives, and a valuation reset based on updated EBITDA assumptions. Analyst Commentary Recent research updates highlight that price targets for Bed Bath & Beyond have been pulled back into the high single digits, with analysts pointing to a mix of operational progress and ongoing execution risk.BBBY: SKU Consolidation And Core Business Inflection Will Support Durable Turnaround
Analysts have trimmed Bed Bath & Beyond's average price target to a range anchored around $7 to $8. This reflects cautious views on execution risks even as they point to early signs of improvement in the core business, including SKU consolidation progress and steadier online trends.
BBBY: Website Momentum And SKU Consolidation Will Support Multiyear Turnaround
Analysts have trimmed their average price target for Bed Bath & Beyond by $0.40. They are tying the shift to mixed Q4 takeaways, where improving core trends and SKU consolidation are being weighed against lower margin expectations and ongoing uncertainty around the multiyear turnaround plan.BBBY: Lemonis Leadership And SKU Consolidation Will Support Renewed Core Business Momentum
Analysts have trimmed their average price target on Bed Bath & Beyond to a range around $7 to $8, reflecting updated P/E assumptions and caution around execution, even as they point to improving website trends and early traction from internal initiatives such as SKU consolidation. Analyst Commentary Recent research updates show that bearish analysts are trimming price targets even as they acknowledge some operational progress in the core business and on initiatives like SKU consolidation.BBBY: Website Momentum And 2027 EBITDA Outlook Will Drive Upside Potential
Analysts have trimmed their fair value estimate for Bed Bath & Beyond from $10.90 to $9.80, tying the lower target to a reduced revenue outlook and higher assumed discount rate, partly balanced by expectations for slightly stronger profit margins and a higher future P/E multiple. Analyst Commentary Recent Street research highlights a mix of optimism and caution around Bed Bath & Beyond, with valuation expectations reset lower even as some early signs in the core business draw interest.BBBY: Leadership Consolidation Under Lemonis Will Support A More Bullish Outlook
Analysts have adjusted their price target on Bed Bath & Beyond to US$7.00, reflecting small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions, while keeping their overall fair value view unchanged at US$7.00. What's in the News On December 30, 2025, Bed Bath & Beyond's Board appointed Executive Chairman and principal executive officer Marcus Lemonis as Chief Executive Officer, effective January 1, 2026.BBBY: Higher US$8 Outlook And Buybacks Will Shape A Cautious Fairly Valued Path
Narrative Update: Bed Bath & Beyond Analyst Price Target Shift Analysts have lifted their 12 month price target on Bed Bath & Beyond to US$8 from US$5, citing refreshed post earnings models that reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary highlights that even with the price target increase to US$8, some research views remain cautious.Revenues Not Telling The Story For Bed Bath & Beyond, Inc. (NYSE:BBBY) After Shares Rise 31%
Jan 23
BBBY: Earnings Refit And Buyback Activity Set A Cautious Path Forward
Analysts lifted their price target on Bed Bath & Beyond to US$8.00 from US$5.00, citing updated earnings assumptions that reflect changes to fair value, discount rate, revenue growth, profit margin and future P/E expectations. Analyst Commentary While the updated price target of US$8.00 reflects refreshed earnings assumptions, bearish analysts still frame the stock as a higher risk proposition rather than a clear upside story.BBBY: Margin Gains And Buyback Support Brighter Outlook Ahead
Analysts have raised their price target on Bed Bath & Beyond to $8 from $5, citing updated post-earnings models that reflect slightly higher profit margin expectations despite more modest projected revenue growth and a higher assumed future valuation multiple. Analyst Commentary Bearish analysts acknowledged that the higher price target reflects improved margin visibility following the latest earnings update, but they emphasized that the new $8 objective still implies limited upside from current levels.Some Bed Bath & Beyond, Inc. (NYSE:BBBY) Shareholders Look For Exit As Shares Take 36% Pounding
Nov 02Bed Bath & Beyond, Inc. (NYSE:BBBY) Analysts Are Pretty Bullish On The Stock After Recent Results
Oct 31Bed Bath & Beyond, Inc.'s (NYSE:BBBY) Shares Climb 31% But Its Business Is Yet to Catch Up
Sep 09E-commerce And Luxury Retail Trends Will Unlock Value
The increase in Beyond's consensus analyst price target from $8.80 to $10.90 is primarily driven by upward revisions in both revenue growth forecasts and future P/E multiples. What's in the News Beyond, Inc.Health Check: How Prudently Does Beyond (NYSE:BYON) Use Debt?
Aug 05Revenues Not Telling The Story For Beyond, Inc. (NYSE:BYON) After Shares Rise 27%
Jul 09What Beyond, Inc.'s (NYSE:BYON) 29% Share Price Gain Is Not Telling You
May 13Beyond: Liberation Day Could Be A Disaster For Margins
Apr 22
Expense Cuts And Vendor Consolidation Will Streamline Operations
Vendor consolidation and SG&A reductions are poised to enhance profitability and strengthen margins by streamlining operations and costs.Beyond Stock.: Iconic Brands Versus Downward Trending Financials
Mar 18Some Beyond, Inc. (NYSE:BYON) Shareholders Look For Exit As Shares Take 30% Pounding
Mar 10Beyond Inc.: Analysts Overly Pessimistic, Recent Trends Likely To Reverse
Feb 07After Leaping 43% Beyond, Inc. (NYSE:BYON) Shares Are Not Flying Under The Radar
Jan 23Beyond: The Perfect Turnaround Storm Could Be Unfolding
Jan 21Is It Beyond Time For Some Changes At Beyond, Inc.?
Nov 13Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Bed Bath & Beyond makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 26 | 1,061 | -61 | 320 | 0 |
| 31 Dec 25 | 1,045 | -85 | 325 | 0 |
| 30 Sep 25 | 1,074 | -145 | 357 | 0 |
| 30 Jun 25 | 1,129 | -202 | 389 | 0 |
| 31 Mar 25 | 1,244 | -225 | 431 | 0 |
| 31 Dec 24 | 1,395 | -259 | 481 | 0 |
| 30 Sep 24 | 1,476 | -339 | 507 | 0 |
| 30 Jun 24 | 1,538 | -341 | 521 | 0 |
| 31 Mar 24 | 1,562 | -371 | 506 | 0 |
| 31 Dec 23 | 1,561 | -308 | 484 | 0 |
| 30 Sep 23 | 1,582 | -164 | 438 | 0 |
| 30 Jun 23 | 1,669 | -138 | 416 | 0 |
| 31 Mar 23 | 1,774 | -56 | 414 | 0 |
| 31 Dec 22 | 1,929 | -37 | 481 | 0 |
| 30 Sep 22 | 2,137 | 9 | 444 | 0 |
| 30 Jun 22 | 2,366 | 74 | 470 | 0 |
| 31 Mar 22 | 2,633 | 118 | 499 | 0 |
| 31 Dec 21 | 2,756 | 134 | 513 | 0 |
| 30 Sep 21 | 2,813 | 126 | 521 | 0 |
| 30 Jun 21 | 2,842 | 134 | 523 | 0 |
| 31 Mar 21 | 2,814 | 127 | 523 | 0 |
| 31 Dec 20 | 2,494 | 91 | 475 | 0 |
| 30 Sep 20 | 2,195 | 42 | 466 | 0 |
| 30 Jun 20 | 1,825 | -25 | 434 | 0 |
| 31 Mar 20 | 1,431 | -95 | 396 | 0 |
| 31 Dec 19 | 1,435 | -62 | 350 | 0 |
| 30 Sep 19 | 1,541 | -139 | 423 | 0 |
| 30 Jun 19 | 1,635 | -154 | 459 | 0 |
| 31 Mar 19 | 1,744 | -193 | 517 | 0 |
| 31 Dec 18 | 1,822 | -205 | 565 | 0 |
| 30 Sep 18 | 1,825 | -253 | 550 | 0 |
| 30 Jun 18 | 1,809 | -207 | 511 | 0 |
| 31 Mar 18 | 1,758 | -151 | 446 | 0 |
| 31 Dec 17 | 1,745 | -107 | 387 | 0 |
| 30 Sep 17 | 1,815 | -11 | 377 | 0 |
| 30 Jun 17 | 1,832 | -13 | 366 | 0 |
| 31 Mar 17 | 1,819 | -7 | 354 | 0 |
| 31 Dec 16 | 1,800 | 13 | 343 | 0 |
| 30 Sep 16 | 1,754 | 10 | 331 | 0 |
| 30 Jun 16 | 1,704 | 11 | 322 | 0 |
| 31 Mar 16 | 1,673 | 13 | 312 | 0 |
| 31 Dec 15 | 1,658 | 2 | 305 | 0 |
| 30 Sep 15 | 1,648 | 4 | 297 | 0 |
| 30 Jun 15 | 1,610 | 7 | 286 | 0 |
Quality Earnings: BBBY is currently unprofitable.
Growing Profit Margin: BBBY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BBBY is unprofitable, and losses have increased over the past 5 years at a rate of 48% per year.
Accelerating Growth: Unable to compare BBBY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BBBY is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (-2.1%).
Return on Equity
High ROE: BBBY has a negative Return on Equity (-30.18%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/04 17:54 |
| End of Day Share Price | 2026/05/01 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bed Bath & Beyond, Inc. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Seth Sigman | Barclays |
| Daniel Kurnos | Benchmark Company |
| Curtis Nagle | BofA Global Research |